Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Dec 10;309(6968):1570–1571. doi: 10.1136/bmj.309.6968.1570

Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.

C J Hawkey 1
PMCID: PMC2541744  PMID: 7819903

Full text

PDF
1570

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Graham D. Y., Hepps K. S., Ramirez F. C., Lew G. M., Saeed Z. A. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993 Nov;28(11):939–942. doi: 10.3109/00365529309098288. [DOI] [PubMed] [Google Scholar]
  2. Hentschel E., Brandstätter G., Dragosics B., Hirschl A. M., Nemec H., Schütze K., Taufer M., Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993 Feb 4;328(5):308–312. doi: 10.1056/NEJM199302043280503. [DOI] [PubMed] [Google Scholar]
  3. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  4. Lamberts R., Creutzfeldt W., Strüber H. G., Brunner G., Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 1993 May;104(5):1356–1370. doi: 10.1016/0016-5085(93)90344-c. [DOI] [PubMed] [Google Scholar]
  5. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  6. Neal K. R., Briji S. O., Slack R. C., Hawkey C. J., Logan R. F. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ. 1994 Jan 15;308(6922):176–176. doi: 10.1136/bmj.308.6922.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sipponen P., Varis K., Fräki O., Korri U. M., Seppälä K., Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol. 1990 Oct;25(10):966–973. doi: 10.3109/00365529008997621. [DOI] [PubMed] [Google Scholar]
  8. Tytgat G. N. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther. 1994 Aug;8(4):359–368. doi: 10.1111/j.1365-2036.1994.tb00303.x. [DOI] [PubMed] [Google Scholar]
  9. Vaira D., Miglioli M., Mulè P., Holton J., Menegatti M., Vergura M., Biasco G., Conte R., Logan R. P., Barbara L. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut. 1994 Mar;35(3):309–312. doi: 10.1136/gut.35.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Valle J., Seppälä K., Sipponen P., Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol. 1991 Oct;26(10):1057–1065. doi: 10.3109/00365529109003956. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES